| scholarly article | Q13442814 |
| P2093 | author name string | M. G. Mattei | |
| B. W. Schäfer | |||
| M. Genini | |||
| P. Schwalbe | |||
| A. Remppis | |||
| F. A. Scholl | |||
| P433 | issue | 4 | |
| P921 | main subject | rhabdomyosarcoma | Q1898141 |
| P304 | page(s) | 433–442 | |
| P577 | publication date | 1997-04-01 | |
| P1433 | published in | DNA and Cell Biology | Q5205740 |
| P1476 | title | Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma | |
| P478 | volume | 16 |
| Q24515126 | A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM |
| Q33292161 | Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein |
| Q52183458 | Amphioxus AmphiDRAL encoding a LIM-domain protein: expression in the epidermis but not in the presumptive neuroectoderm |
| Q24554293 | Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription |
| Q24297493 | BRCA1 interacts with FHL2 and enhances FHL2 transactivation function |
| Q33196058 | Characterization of recombinant and natural forms of the human LIM domain-containing protein FHL2. |
| Q28144167 | Characterization of two isoforms of the skeletal muscle LIM protein 1, SLIM1. Localization of SLIM1 at focal adhesions and the isoform slimmer in the nucleus of myoblasts and cytoplasm of myotubes suggests distinct roles in the cytoskeleton and [...] |
| Q24683786 | DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis |
| Q37696275 | Dependence receptors: a new paradigm in cell signaling and cancer therapy |
| Q33254909 | Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice |
| Q45877400 | Downregulation and antiproliferative role of FHL3 in breast cancer |
| Q48000638 | Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo |
| Q37003274 | Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancer |
| Q34479719 | Expression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study |
| Q41749359 | Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system |
| Q39455832 | FHL2 (SLIM3) is not essential for cardiac development and function |
| Q39304395 | FHL2 binds calcineurin and represses pathological cardiac growth |
| Q34206722 | FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer |
| Q47871595 | FHL2 interacts with EGFR to promote glioblastoma growth |
| Q40115712 | FHL2 mediates tooth development and human dental pulp cell differentiation into odontoblasts, partially by interacting with Runx2. |
| Q35137904 | FHL2 regulates hematopoietic stem cell functions under stress conditions |
| Q24601620 | FHL2, a novel tissue-specific coactivator of the androgen receptor |
| Q28507893 | FHL3 is an actin-binding protein that regulates alpha-actinin-mediated actin bundling: FHL3 localizes to actin stress fibers and enhances cell spreading and stress fiber disassembly |
| Q38804262 | Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma |
| Q60492745 | Four-and-a-half LIM domains protein 2 (FHL2) is associated with the development of craniofacial musculature in the teleost fish Sparus aurata |
| Q82499572 | Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy |
| Q28216665 | Identification of the LIM protein FHL2 as a coactivator of beta-catenin |
| Q41959511 | Interaction of TACC proteins with the FHL family: implications for ERK signaling |
| Q36413193 | KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2. |
| Q34793699 | Muscle giants: molecular scaffolds in sarcomerogenesis |
| Q81886839 | Oncogene functions of FHL2 are independent from NF-kappaBIalpha in gastrointestinal cancer |
| Q39391006 | Overview of the Muscle Cytoskeleton |
| Q24297205 | PC4 coactivates MyoD by relieving the histone deacetylase 4-mediated inhibition of myocyte enhancer factor 2C. |
| Q28280935 | Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2 |
| Q40426734 | Roles of LIM proteins in cardiac hypertrophy |
| Q33586638 | Scaffold protein FHL2 facilitates MDM2-mediated degradation of IER3 to regulate proliferation of cervical cancer cells |
| Q33677015 | Signaling routes to CREM and CREB: plasticity in transcriptional activation. |
| Q24293737 | Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation |
| Q39664035 | Synergistic repression of estrogen receptor transcriptional activity by FHL2 and Smad4 in breast cancer cells |
| Q33411086 | Systematic identification of genes involved in divergent skeletal muscle growth rates of broiler and layer chickens |
| Q33292102 | TUCAN/CARDINAL and DRAL participate in a common pathway for modulation of NF-kappaB activation. |
| Q38554494 | The FHL2 regulation in the transcriptional circuitry of human cancers |
| Q34317218 | The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells |
| Q22008818 | The LIM proteins FHL1 and FHL3 are expressed differently in skeletal muscle |
| Q64078688 | The LIM-Only Protein FHL2 is involved in Autophagy to Regulate the Development of Skeletal Muscle Cell |
| Q22254650 | The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes |
| Q28216196 | The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein |
| Q31113643 | The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts |
| Q24323174 | The LIM-only protein FHL2 is a negative regulator of E4F1 |
| Q33781653 | The T-cell oncogenic protein HOX11 activates Aldh1 expression in NIH 3T3 cells but represses its expression in mouse spleen development |
| Q51798327 | The expression pattern of FHL2 during mouse molar development. |
| Q37151504 | The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription |
| Q42556696 | The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcription. |
| Q39963131 | The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities |
| Q34485166 | The sarcomeric Z-disc: a nodal point in signalling and disease |
| Q33851832 | Transcriptional regulation by cyclic AMP-responsive factors |
| Q33928772 | Translocation of a human focal adhesion LIM-only protein, FHL2, during myofibrillogenesis and identification of LIM2 as the principal determinants of FHL2 focal adhesion localization |
| Q89576438 | Up-regulated FHL2 inhibits ovulation through interacting with androgen receptor and ERK1/2 in polycystic ovary syndrome |
Search more.